Jiasheng Song

This inventor holds 8 USPTO granted patents and 5 published patent applications, plus 6 CIPO patents and 2 EPO patents. Top assignees: Ahr Pharmaceuticals, Inc., Ariagen, Inc., Wisconsin Alumni Research Foundation. Active years: 2005-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiasheng Song. Retrieved from https://idiyas.com/inventor/jiasheng-song

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 5)

% Patents Active = 75.0

CIPO Patents = 6

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 1.4

ph-index = 3

Forward Citations = 34(Granted Patents)

Company Filing History:

3 out of 3

Ahr Pharmaceuticals, Inc.

Wisconsin Alumni Research Foundation

patents

Years Active: 2005-2020

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10632106 - Methods of cancer treatment with 2-(1'H-Indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (2020-04-28),

2. 10195182 - ITE for cancer intervention and eradication (2019-02-05),

3. 10081610 - Efficient and scalable synthesis of 2-(1'h-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester and its structural analogs (2018-09-25),

4. 9694000 - ITE for cancer intervention and eradication (2017-07-04),

5. 9238645 - ITE for cancer intervention and eradication (2016-01-19),

6. 8604067 - ITE for cancer intervention and eradication (2013-12-10),

7. 7419992 - Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders (2008-09-02),

8. 6916834 - Preparations and use of an Ah receptor ligand, 2-(1'H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (2005-07-12),

Title: The Innovative Contributions of Jiasheng Song in Cancer Treatment

Introduction

Jiasheng Song is a prominent inventor based in Madison, WI, known for his groundbreaking advancements in cancer treatment therapies. With an impressive portfolio of 8 patents, he has made significant strides in developing methods aimed at combating various forms of cancer.

Latest Patents

Among his latest patents, Song has introduced methods involving 2-(1'H-Indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester. These innovative methods leverage the aryl hydrocarbon (Ah) receptor (AhR) and its endogenous ligand, ITE, to provide effective cancer treatments. His patents disclose strategies for administering ITE or its structural analogs to patients suffering from a range of cancers, including prostate, liver, lung, ovarian, breast, skin, colon (or rectum), stomach, pancreatic, kidney, bladder, soft tissue, or cervical cancer. Additionally, one of his patents outlines a method for cancer intervention or eradication, focusing on tailored dosing based on blood levels of the active ingredient, ensuring optimal treatment effectiveness.

Career Highlights

Throughout his career, Jiasheng Song has worked with noteworthy companies such as Ahr Pharmaceuticals, Inc. and Ariagen, Inc. These experiences have undoubtedly contributed to his expertise and success in the realm of cancer research and treatment innovation.

Collaborations

Song has collaborated with esteemed colleagues in his field, including Hector Floyd Deluca and Margaret Clagett-Dame. Their combined efforts in research and development have propelled advancements that continue to influence cancer treatment protocols.

Conclusion

Jiasheng Song's dedication to innovation and his contributions to cancer treatment methodologies highlight the vital role inventors play in advancing medical science. His work not only serves as an inspiration to future inventors but also offers hope for patients battling cancer. The pursuit of effective therapies remains crucial, and inventors like Song are at the forefront of this essential quest.

Profile summary based on public USPTO records.